Showing results (1681-1690 of 1,859) with videos related to

Sort By:
Pageof 186
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 17, 2006
Liver transplant candidacy unsuitability: a review of the British Columbia experienceJaber Alali, Alnoor Ramji, Jin K Ho, et al.
Osteoarthritis and Cartilage|April 20, 2004
Two knees or not two knees? Patient costs and outcomes following bilateral and unilateral total knee joint replacement surgery for OAL M March, M Cross, K L Tribe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trialJeffrey M Burns, Jill K Morris, Eric D Vidoni, et al.
Plos One|July 15, 2026
Examining the feasibility and preliminary effects of resistance exercise training and creatine supplementation in individuals treated for colorectal cancerCiaran M Fairman, Alex M Brooks, Darren G Candow, et al.
The Science of the Total Environment|September 5, 2025
Wastewater surveillance of SARS-CoV-2 and influenza in a dynamic university community: understanding how wastewater measurements correspond to reported casesMatthew J Jones, Rukayya Ibrahim, Shirley Clark, et al.
Circulation|December 31, 1997
Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgeryM A Hlatky, C Bacon, D Boothroyd, et al.
European Journal of Preventive Cardiology|September 20, 2015
Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopauseSamar R El Khoudary, Nanette Santoro, Hsiang-Yu Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's diseaseC P Smith, G M Bores, W Petko, et al.
Toxicologic Pathology|March 20, 2008
Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adultsLilian Calderón-Garcidueñas, Anna C Solt, Carlos Henríquez-Roldán, et al.
Pageof 186